Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
InnoCare Pharma Ltd. ( (HK:9969) ) just unveiled an announcement.
InnoCare Pharma Limited has announced a board meeting scheduled for May 13, 2025, to review and approve the company’s unaudited first quarterly results for the period ending March 31, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market position and stakeholder interests.
More about InnoCare Pharma Ltd.
InnoCare Pharma Limited is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for the treatment of cancer and autoimmune diseases.
YTD Price Performance: 65.69%
Average Trading Volume: 12,796,074
Technical Sentiment Signal: Sell
Current Market Cap: HK$15.17B
Find detailed analytics on 9969 stock on TipRanks’ Stock Analysis page.